We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 1BMRN market cap is 10.52B. The company's latest EPS is USD 2.2375 and P/E is 28.29.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.86B | 1.85B | 2.1B | 2.42B | 2.85B |
| Operating Income | -96.27M | -20.41M | 41.56M | 185.8M | 490.66M |
| Net Income | 859.1M | -2.15M | 141.56M | 167.65M | 426.86M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.85B | 6B | 6.38B | 6.84B | 6.99B |
| Total Liabilities | 1.74B | 1.73B | 1.77B | 1.89B | 1.33B |
| Total Equity | 4.11B | 4.27B | 4.6B | 4.95B | 5.66B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 85.37M | 304.54M | 175.9M | 159.26M | 572.84M |
| Investing | -53.62M | -366.31M | -20.03M | -111.24M | 136.49M |
| Financing | 181.12M | -48k | -18.65M | -18.73M | -526.45M |
| Market Cap | 10.52B |
| Price to Earnings Ratio | 28.29 |
| Price to Sales Ratio | 4.23 |
| Price to Cash Ratio | 12.81 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 190.78M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 25 |
| 52 Week Change | -21.56% |
| 52 Week High | 84.04 |
| 52 Week Low | 51.70 |
| Spread (Intraday) | 1.24 (2.23%) |
| Company Name | Biomarin Phar Dl 001 |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.biomarin.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
